Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, Dec. 18, 2014 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium") (TSX:TR) (OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today...
-
Trillium Therapeutics Provides Corporate Update and Announces Reverse Stock Split for NASDAQ Listing
TORONTO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium") (TSX:TR) (OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today...
-
TORONTO, ONTARIO--(Marketwired - Aug. 7, 2014) - Trillium Therapeutics Inc. ("Trillium") (TSX:TR)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the...
-
TORONTO, ONTARIO--(Marketwired - June 13, 2014) - Trillium Therapeutics Inc. ("TTI") (TSX:TR)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the...
-
TORONTO, ONTARIO--(Marketwired - June 2, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX:SSS)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment...
-
TORONTO, ONTARIO--(Marketwired - May 28, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX:SSS)(OTCQX:SCTPF), an immuno-oncology company developing innovative therapies for the treatment...
-
TORONTO, ONTARIO--(Marketwired - April 21, 2014) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related...
-
TORONTO, ONTARIO--(Marketwired - April 3, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
-
TORONTO, CANADA--(Marketwired - March 10, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
-
TORONTO, ONTARIO--(Marketwired - Jan. 30, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...